Atrás
Rango del Día
$71.94
$74.49
Rango de 52 Semanas
$6.45
$77.00
Volumen
698,521
Promedio 50D / 200D
$56.05
/
$44.68
Cierre Anterior
$72.22
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -9.2 | 0.4 |
| P/B | 16.8 | 2.9 |
| ROE % | -217.9 | 3.8 |
| Net Margin % | -297.1 | 3.9 |
| Rev Growth 5Y % | -14.2 | 10.0 |
| D/E | 1.7 | 0.2 |
Precio Objetivo de Analistas
Hold
$136.40
+83.5%
Low: $105.00
High: $165.00
EPS Futuro
-$10.10
Ingresos Est.
41 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$10.44
-$12.84 – -$3.55
|
210 M | 6 |
| FY2029 |
-$12.81
-$15.75 – -$4.35
|
110 M | 6 |
| FY2028 |
-$12.96
-$19.89 – -$9.78
|
54 M | 8 |
Puntos Clave
Revenue declined -14.20% annually over 5 years
Negative free cash flow of -208.68M
Revenue growth is decelerating — 1Y growth trails 5Y average by 29.69%
Capital efficient — spends only 0.31% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-14.20%
Revenue (1Y)-43.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-217.94%
ROIC-41.08%
Net Margin-297.07%
Op. Margin-236.77%
Seguridad
Debt / Equity
1.66
Current Ratio4.97
Interest Coverage-4.99
Valoración
P/E Ratio
-9.20
P/B Ratio16.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -43.89% | Revenue Growth (3Y) | -21.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14.20% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 55.23M | Net Income (TTM) | -164.08M |
| ROE | -217.94% | ROA | -58.51% |
| Gross Margin | 100.00% | Operating Margin | -236.77% |
| Net Margin | -297.07% | Free Cash Flow (TTM) | -208.68M |
| ROIC | -41.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.66 | Current Ratio | 4.97 |
| Interest Coverage | -4.99 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.20 | P/B Ratio | 16.80 |
| P/S Ratio | 27.32 | PEG Ratio | -0.36 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.51B | Enterprise Value | 1.64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55.23M | 98.43M | 90.12M | 92.06M | 101.91M |
| Net Income | -164.08M | -118.96M | -276.06M | -368.20M | -523.84M |
| EPS (Diluted) | -9.73 | -8.68 | -21.79 | -29.51 | -42.90 |
| Gross Profit | 55.23M | 67.74M | 53.48M | 70.42M | 77.01M |
| Operating Income | -130.77M | -105.20M | -137.43M | -240.24M | -446.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 280.41M | 303.85M | 398.03M | 710.60M | 1.12B |
| Total Liabilities | 190.57M | 243.11M | 267.05M | 343.96M | 437.68M |
| Shareholders' Equity | 89.83M | 60.74M | 130.99M | 366.64M | 679.51M |
| Total Debt | 148.91M | 102.56M | 117.78M | 131.50M | 143.18M |
| Cash & Equivalents | 15.12M | 44.25M | 35.28M | 88.23M | 25.22M |
| Current Assets | 266.27M | 261.29M | 330.70M | 545.97M | 795.58M |
| Current Liabilities | 53.54M | 61.40M | 51.27M | 68.20M | 85.20M |